NSC |
Compound |
Enrichment |
Correlation |
NSC 692580 |
Null |
0.0171439890681608 |
0.52564069 |
NSC 694000 |
2-Butenedioic acid, (E)-, 2-[3-[[[[2-(acetyloxy)ethoxy] methyl]-3H-1,2,3-triazol-4-yl]methyl]- 1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-,diethyl ester |
0.0171439890681608 |
0.45177431 |
NSC 694002 |
2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester |
0.0171439890681608 |
0.49644846 |
NSC 697886 |
17-Demethoxy-17-allylamino geldanamycin-11-[4-(dimethylamino)butyrate] |
0.0171439890681608 |
0.24761396 |
NSC 698408 |
Null |
0.0171439890681608 |
0.22524148 |
NSC 700913 |
Null |
0.0171439890681608 |
0.36553075 |
NSC 702158 |
7-epi-3,4-bis-nor-dolastatin 11 |
0.0171439890681608 |
0.13611322 |
NSC 714187 |
3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate |
0.0171439890681608 |
0.20178128 |
NSC 724058 |
3-[(N,N-Dimethylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8 ,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.0171439890681608 |
0.25899836 |
NSC 727987 |
NSC 708783 incorporated in micelles, 0.20% (w/w) of drug |
0.0171439890681608 |
0.20631223 |